Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura A. Goguen, M.D.

Concepts (218)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms35202429312.090 Why?
Carcinoma, Squamous Cell24202440581.130 Why?
Neck Dissection520112011.020 Why?
Esophageal Stenosis520131960.960 Why?
Osteoradionecrosis22022510.950 Why?
Free Tissue Flaps220243370.760 Why?
Dilatation320133110.740 Why?
Deglutition Disorders620166400.660 Why?
Radiotherapy, Intensity-Modulated920227980.610 Why?
Surgery, Computer-Assisted1202210030.470 Why?
Oropharyngeal Neoplasms520224930.460 Why?
Teratoma120164050.440 Why?
Esophagoscopy220133980.420 Why?
Granular Cell Tumor12012480.400 Why?
Radiotherapy, Adjuvant8201117910.390 Why?
Mouth Neoplasms420245970.390 Why?
Tracheal Neoplasms120121240.380 Why?
Chemotherapy, Adjuvant6201635560.360 Why?
Neoadjuvant Therapy5202329070.360 Why?
Deglutition120112080.340 Why?
Enophthalmos12008340.300 Why?
Maxillary Sinusitis12008410.290 Why?
Paranasal Sinus Diseases120081210.280 Why?
Malacoplakia12006150.280 Why?
Maxillary Sinus120081750.270 Why?
Otorhinolaryngologic Neoplasms12006260.270 Why?
Tongue Diseases12006690.260 Why?
Orbital Diseases120081780.250 Why?
Antineoplastic Combined Chemotherapy Protocols122021118780.240 Why?
Taxoids820126670.230 Why?
Neoplasms, Unknown Primary220191020.230 Why?
Facial Neuralgia12003100.230 Why?
Toothache12003310.220 Why?
Combined Modality Therapy13201185420.220 Why?
Pharyngectomy12003450.220 Why?
Nucleic Acid Synthesis Inhibitors120031090.220 Why?
Pharyngeal Diseases220041340.210 Why?
Thyroid Neoplasms1201623600.210 Why?
Mitomycin120032610.210 Why?
Laryngectomy220052450.200 Why?
Precancerous Conditions220249850.180 Why?
Middle Aged4220242234870.180 Why?
Acupuncture Therapy220164860.170 Why?
Laryngeal Neoplasms320115140.160 Why?
Aged3520241715020.150 Why?
Microsurgery120038000.150 Why?
Endoscopy1200818540.150 Why?
Neoplasms, Squamous Cell22009950.140 Why?
Retrospective Studies192024817600.140 Why?
Neoplasm Staging72024112440.140 Why?
Triage120249970.140 Why?
Male4420243647310.140 Why?
Neoplasm Recurrence, Local7202494190.140 Why?
Female4420243971870.140 Why?
Radiation Injuries2201911980.140 Why?
Papillomavirus Infections2202216400.130 Why?
Salivary Gland Neoplasms120203060.130 Why?
Qualitative Research2202431400.130 Why?
Parotitis11995280.130 Why?
Barotrauma11995410.130 Why?
Hyperbaric Oxygenation120171660.130 Why?
Paclitaxel6201217330.130 Why?
Treatment Outcome162021653790.130 Why?
Air119951870.120 Why?
Adult3020242236460.120 Why?
Humans5620247681710.120 Why?
Nose Diseases11995780.120 Why?
Surgical Flaps1200316820.120 Why?
Fluorouracil8201216520.120 Why?
Radiotherapy Dosage6202229160.110 Why?
Aged, 80 and over142024596260.110 Why?
Cisplatin8201216600.110 Why?
Postoperative Complications32021158330.100 Why?
S100 Proteins120122160.100 Why?
Lymphatic Metastasis3201029140.100 Why?
Hypopharyngeal Neoplasms12011520.090 Why?
Class I Phosphatidylinositol 3-Kinases120169050.090 Why?
Referral and Consultation1202436200.090 Why?
Tomography, X-Ray Computed32010207620.090 Why?
Human papillomavirus 16120122680.090 Why?
Patient Acceptance of Health Care1202332310.080 Why?
Self-Injurious Behavior119955680.080 Why?
Gastrostomy120113250.080 Why?
Carboplatin520127970.070 Why?
Proto-Oncogene Proteins p21(ras)1201617670.070 Why?
Cohort Studies62024417530.070 Why?
Disease-Free Survival4202168470.070 Why?
Survival Rate42010128400.070 Why?
Cancer Care Facilities320194270.070 Why?
Relative Biological Effectiveness120083130.070 Why?
Proportional Hazards Models42019125430.070 Why?
Follow-Up Studies52013393540.070 Why?
Hypopharynx12004530.060 Why?
Radiotherapy, Conformal120085490.060 Why?
Respiration Disorders120083640.060 Why?
Survival Analysis52019100990.050 Why?
Leucovorin220036430.050 Why?
Leukoplakia, Oral12024790.050 Why?
Larynx120084920.050 Why?
Carcinoma, Adenoid Cystic120062630.050 Why?
Pharyngeal Neoplasms120031130.050 Why?
Constriction, Pathologic2200411040.050 Why?
Eating1201015420.050 Why?
Gastroscopy120042130.050 Why?
Neoplasms, Second Primary1201010610.050 Why?
Tuberculosis1199520290.050 Why?
Pilot Projects4202187410.050 Why?
Patient Selection2201242600.050 Why?
Antineoplastic Agents22023136770.050 Why?
Syndrome1200832730.050 Why?
Administration, Topical120037040.050 Why?
Risk Assessment32019243180.050 Why?
Parotid Gland120221780.050 Why?
Kaplan-Meier Estimate3201965250.050 Why?
Recovery of Function1201129810.050 Why?
Regression Analysis1201063400.050 Why?
Hospitalization12020108400.040 Why?
Prognosis52024300090.040 Why?
Tumor Microenvironment2202439480.040 Why?
Severity of Illness Index22011159490.040 Why?
Organs at Risk120223670.040 Why?
Acute Disease2200372430.040 Why?
Laryngoscopy120047140.040 Why?
Quality of Life42024134900.040 Why?
Salvage Therapy2202112730.040 Why?
Immunohistochemistry12012110950.040 Why?
Sulfonamides1200819820.040 Why?
Pyrazoles1200820280.040 Why?
Prostatic Neoplasms12020111010.040 Why?
CD8-Positive T-Lymphocytes2202346480.040 Why?
Maximum Tolerated Dose220098990.030 Why?
Jaw12017950.030 Why?
Interviews as Topic1202427410.030 Why?
Cyclin-Dependent Kinase Inhibitor p1812016530.030 Why?
Mucous Membrane120196590.030 Why?
Chronic Disease2200393840.030 Why?
Polymerase Chain Reaction1202460820.030 Why?
Bone Lengthening11994200.030 Why?
Predictive Value of Tests12010154530.030 Why?
Cyclin D1120164530.030 Why?
Radiation Dosage1202219670.030 Why?
Radiotherapy Planning, Computer-Assisted1202216790.030 Why?
Esophageal Neoplasms1200316680.030 Why?
Receptor, Notch1120165190.030 Why?
Breast Neoplasms12020212070.030 Why?
Cyclin-Dependent Kinase Inhibitor p16120167100.030 Why?
Treatment Failure2201226610.020 Why?
Androgen Antagonists1202014120.020 Why?
SEER Program1201614440.020 Why?
Xerostomia12010940.020 Why?
Health Personnel1202333840.020 Why?
Papillomaviridae1201611400.020 Why?
Patient Dropouts120124110.020 Why?
Radiation Tolerance120124760.020 Why?
Mandible119947590.020 Why?
Self Concept1199510430.020 Why?
Receptor, erbB-21202026030.020 Why?
Albumins120125770.020 Why?
Antibodies, Monoclonal3201292620.020 Why?
Feasibility Studies2201253150.020 Why?
Killer Cells, Natural1201822110.020 Why?
Retreatment120105980.020 Why?
DNA1202272130.020 Why?
Prospective Studies22020549240.020 Why?
Magnetic Resonance Imaging22012367410.020 Why?
Oncogene Protein v-akt120081300.020 Why?
Diet1200680890.020 Why?
Patient Discharge1202134790.020 Why?
Boston2201193740.020 Why?
Immunotherapy1202447540.020 Why?
Incidence12006215380.020 Why?
Osteogenesis1199412950.020 Why?
Length of Stay1202164980.020 Why?
Dose-Response Relationship, Drug22009107630.020 Why?
Dose-Response Relationship, Radiation120088760.020 Why?
Ki-67 Antigen120086300.020 Why?
Adolescent42023891690.020 Why?
Clinical Protocols1201214430.020 Why?
Cyclooxygenase 2120085980.020 Why?
Adenocarcinoma1200363950.020 Why?
Dinoprostone120085970.020 Why?
Tumor Suppressor Protein p531201629560.020 Why?
Base Sequence12016124220.010 Why?
Young Adult32017600660.010 Why?
Neoplasm Proteins1201636040.010 Why?
Quality Improvement1201938570.010 Why?
Organ Specificity1200819680.010 Why?
High-Throughput Nucleotide Sequencing1201636700.010 Why?
Recurrence1199585090.010 Why?
Antineoplastic Agents, Phytogenic120066220.010 Why?
Gene Expression Regulation, Neoplastic1201886480.010 Why?
Proto-Oncogene Proteins c-bcl-21200814060.010 Why?
Cross-Sectional Studies12022263790.010 Why?
Clinical Trials, Phase I as Topic120033300.010 Why?
Disease Progression22009136680.010 Why?
Remission Induction1200624100.010 Why?
Clinical Trials, Phase II as Topic120036400.010 Why?
Granulocyte Colony-Stimulating Factor120036310.010 Why?
Diagnosis, Differential11995130130.010 Why?
Gene Expression Profiling1201695400.010 Why?
Patient Compliance1200926970.010 Why?
DNA-Binding Proteins1201696170.010 Why?
Double-Blind Method12012124660.010 Why?
Drug Resistance, Neoplasm1201253410.010 Why?
Research Design1201262090.010 Why?
Language Tests119951930.010 Why?
Drug Administration Schedule1200348610.010 Why?
Psychological Tests119956430.010 Why?
Personality119955590.010 Why?
Child21995809170.010 Why?
Dogs1199438450.010 Why?
Affect1199514950.000 Why?
Sex Factors11995106320.000 Why?
Risk Factors12008749440.000 Why?
Age Factors11995184150.000 Why?
Cognition1199570730.000 Why?
Depression1199582300.000 Why?
Animals119941692850.000 Why?
Goguen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (218)
Explore
_
Co-Authors (70)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.